The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma.
about
Individualized 131I-mIBG therapy in the management of refractory and relapsed neuroblastoma.Extended Sedation With Continuous Midazolam or Dexmedetomidine Infusion for Young Children Receiving 131 I-MIBG Radiopharmaceutical Therapy for Advanced Neuroblastoma.Iodine-131 metaiodobenzylguanidine therapy for neuroblastoma: reports so far and future perspective.
P2860
The role of 131I-metaiodobenzylguanidine (MIBG) therapy in unresectable and compromising localised neuroblastoma.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 June 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The role of 131I-metaiodobenzy ...... ising localised neuroblastoma.
@en
The role of 131I-metaiodobenzylguanidine
@nl
type
label
The role of 131I-metaiodobenzy ...... ising localised neuroblastoma.
@en
The role of 131I-metaiodobenzylguanidine
@nl
prefLabel
The role of 131I-metaiodobenzy ...... ising localised neuroblastoma.
@en
The role of 131I-metaiodobenzylguanidine
@nl
P2093
P2860
P1476
The role of 131I-metaiodobenzy ...... ising localised neuroblastoma.
@en
P2093
Berthe L van Eck
Gitta Bleeker
Godelieve A Tytgat
Hugo A Heij
Huib N Caron
Jan de Kraker
Reineke A Schoot
P2860
P2888
P304
P356
10.1007/S00259-013-2455-2
P577
2013-06-06T00:00:00Z